Knowledge Distillery

Experience in multiple sclerosis patients with COVID-19 and disease-modifying therapies: a review of 873 published cases

In this article the authors conducted a single-center, open-label, non-randomized, Phase 1 trial in India between July 2020 and October 2020.

Drug treatments for COVID-19: living systematic review and network meta-analysis

The objective of this retrospective cross-sectional study was to generate real-world multiple sclerosis–specific vaccine safety information,…

COVID-19 in MS patients: susceptibility, severity risk factors and serological response

This phase 3 trial randomly assigned a cohort of patients with mild or moderate COVID-19 who were at high risk for progression to severe disease to…

Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study

This narrative review was conducted to collect and discuss published data about neurological side effects of SARS-CoV-2 vaccines in order to discover…

Meta-analysis of EEG findings in patients with COVID-19

In this article the authors assess 88 health care workers who had received one dose of ChAdOx1 nCoV-19 vaccine 9 to 12 weeks earlier. Among these…

Prevalence, clinical characteristics and outcomes of Guillain‐Barré syndrome spectrum associated with COVID‐19: a systematic review and meta‐analysis …

In this case-control study, the authors evaluated NSSS from a cohort of 7,812,845 BNT162b2 first-dose recipients, of whom 10,929 reported an adverse…